Related references
Note: Only part of the references are listed.Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan Silverberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature
Ana B. Pavel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis
Helen He et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis
Helen He et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis
Flavien Huet et al.
ACTA DERMATO-VENEREOLOGICA (2019)
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis
Lisa Zhou et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Association of Atopic Dermatitis With Sleep Quality in Children
Faustine D. Ramirez et al.
JAMA PEDIATRICS (2019)
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study
R. Bissonnette et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts
Yuki M. F. Andersen et al.
DIABETES CARE (2019)
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B. Pavel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
JAK Inhibitors for Atopic Dermatitis: An Update
Helen He et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
Zelma C. Chiesa Fuxench et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Assessment of IL-31 levels and disease severity in children with atopic dermatitis
D. Ozceker et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2018)
Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease
Yun Shen et al.
CARDIOLOGY (2018)
Serum biomarker profiles suggest that atopic dermatitis is a systemic disease
Judith L. Thijs et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures
Huei-Chi Wen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Eric L. Simpson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
Ishan Lakhani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Pain and Itch Are Dual Burdens in Atopic Dermatitis
Melody Maarouf et al.
DERMATITIS (2018)
IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity
Ayako Takamori et al.
SCIENTIFIC REPORTS (2018)
Expansion of circulating follicular T helper cells associates with disease severity in childhood atopic dermatitis
Krisztina Szabo et al.
IMMUNOLOGY LETTERS (2017)
Expression levels of transcription factor PU.1 and interleukin-9 in atopic dermatitis and their relation to disease severity and eruption types
Ashraf M. Hamza et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease
Benjamin Ungar et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
An association of periostin levels with the severity and chronicity of atopic dermatitis in children
Myongsoon Sung et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2017)
The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins
Patrick M. Brunner et al.
SCIENTIFIC REPORTS (2017)
Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis
Hwan Soo Kim et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)
Association of Circulating IGFBP1 Level with the Severity of Coronary Artery Lesions in Patients with Unstable Angina
Wei Zheng et al.
DISEASE MARKERS (2017)
Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis
Britta C. Martel et al.
EXPERIMENTAL DERMATOLOGY (2016)
Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes
Jaehwan Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Foxp3+ regulatory T cells are expanded in severe atopic dermatitis patients
L. M. Roesner et al.
ALLERGY (2015)
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis
Lars Lind et al.
ATHEROSCLEROSIS (2015)
Biomarkers for atopic dermatitis: a systematic review and meta-analysis
Judith Thijs et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis
Chao-Ying Gu et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
Shinji Noda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Skin Barrier Defects in Atopic Dermatitis
Rachana Agrawal et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort
David J. Margolis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
Julia K. Gittler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Mark Boguniewicz et al.
IMMUNOLOGICAL REVIEWS (2011)
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response
Suzanne Tintle et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Methylation profiling of DNA in the area of atherosclerotic plaque in humans
M. S. Nazarenko et al.
MOLECULAR BIOLOGY (2011)
Recent insights into atopic dermatitis and implications for management of infectious complications
Mark Boguniewicz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
IL-22-producing T22 T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells
Kristine E. Nograles et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Structures and biological functions of IL-31 and IL-31 receptors
Qing Zhang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
A population-based survey of eczema prevalence in the united states
Ion M. Hanifin et al.
DERMATITIS (2007)
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
Yisong Y. Wan et al.
NATURE (2007)
Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis
K Jahnz-Rozyk et al.
ALLERGY (2005)
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis
DJ Hijnen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Serum concentration of IL-18 correlates with disease extent in young children with atopic dermatitis
KL Ellis et al.
PEDIATRIC DERMATOLOGY (2004)
Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children
TF Leung et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2003)
Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris
T Kakinuma et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis
M Toyoda et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis
T Kakinuma et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Share Paper
